The selected biomarker analysis in five types of uterine smooth muscle tumors.

about

The selected biomarker analysis in five types of uterine smooth muscle tumors.

Item

http://www.wikidata.org/entity/Q52408160

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The selected biomarker analysis in five types of uterine smooth muscle tumors.

@en

The selected biomarker analysis in five types of uterine smooth muscle tumors.

@nl

type

Item

label

The selected biomarker analysis in five types of uterine smooth muscle tumors.

@en

The selected biomarker analysis in five types of uterine smooth muscle tumors.

@nl

prefLabel

The selected biomarker analysis in five types of uterine smooth muscle tumors.

@en

The selected biomarker analysis in five types of uterine smooth muscle tumors.

@nl

P1476

The selected biomarker analysis in 5 types of uterine smooth muscle tumors

@en

P2093

Anna E Strohl

http://www.w3.org/2001/XMLSchema#string

Beihua Kong

http://www.w3.org/2001/XMLSchema#string

Dachao Liu

http://www.w3.org/2001/XMLSchema#string

Denise M Scholtens

http://www.w3.org/2001/XMLSchema#string

John R Lurain

http://www.w3.org/2001/XMLSchema#string

Julianne Ubago

http://www.w3.org/2001/XMLSchema#string

Margaux Jenna Kanis

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Shohreh Shahabi

http://www.w3.org/2001/XMLSchema#string

P2860

High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling

Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.

MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors.

Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors

The biology of uterine sarcomas: A review and update.

Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.

Uterine leiomyosarcoma: a review article.

Novel fumarate hydratase mutation in a family with atypical uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer.

P304

17-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HUMPATH.2017.12.005

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jian-Jun Wei

P577

2017-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29258902

http://www.w3.org/2001/XMLSchema#string

P932

6065267

http://www.w3.org/2001/XMLSchema#string